Results 71 to 80 of about 15,768 (275)
Methimazole Associated Neutropenia in a Preterm Neonate Treated for Hyperthyroidism
Case Reports in Endocrinology, 2015 Maternal Graves’ disease is relatively uncommon with an estimated incidence of 0.4%–1% of all pregnancies, but only 1–5% of newborns delivered to mothers with Graves’ disease develop overt clinical signs and symptoms of hyperthyroidism. Here, we describe
Dimitrios Angelis +2 more
doaj +1 more source
Hyperthyroidism in cats, part II : scintigraphic diagnosis and radioiodine treatment [PDF]
, 2016 In the second part of this review article, the diagnostic aspects of thyroid scintigraphy are discussed, with major emphasis on hyperthyroidism, followed by an overview of radioiodine ...
Daminet, Sylvie +4 more
core +1 more source
Drug metabolism by flavin-containing monooxygenases of human and mouse [PDF]
, 2016 Introduction: Flavin-containing monooxygenases (FMOs) play an important role in drug metabolism. / Areas covered: We focus on the role of FMOs in the metabolism of drugs in human and mouse.
Phillips, IR, Shephard, EA
core +1 more source
F1000ResearchA 56-year-old female with a medical history of unspecified hyperthyroidism and a recent thyroid storm presented to the ED with tachycardia, hypertension, and bilateral enlarged parotid glands.
Ricky Rana +3 more
doaj +1 more source
Managing thyroid dysfunction in selected special situations [PDF]
, 2013 Managing thyroid dysfunction is simple at first glance, the idea is to bring hormone levels in the euthyroid range, treat with antithyroid drugs, radio-iodine or surgery if toxic and replace with thyroxine or T3 if hypothyroid.
Durr e Sabih, Mohammad Inayatullah
core +1 more source
Effects of methimazole on the elimination of irinotecan [PDF]
Cancer Chemotherapy and Pharmacology, 2010 To study the possible pharmacokinetic and pharmacodynamic interactions between irinotecan and methimazole.A patient treated for colorectal cancer with single agent irinotecan received methimazole co-medication for Graves' disease. Irinotecan pharmacokinetics and side effects were followed during a total of four courses (two courses with and two courses
van der Bol, J.M. +9 more
openaire +4 more sources
ChemistryEurope, Volume 4, Issue 2, February 2026.The cis‐2,3‐bis(trifluoromethyl)cyclopropyl chemotype is introduced. The steric demand of this motif is intermediate between that of the heptafluoroisopropyl and prefluorotertbutyl groups; yet, it induces significantly less lipophilicity than these due to its facial polarity.
Daniel Gaviña +5 more
wiley +1 more source
Acute Drug-Induced Cholestatic Syndrome in Basedow Graves’ Disease
Journal of Interdisciplinary Medicine, 2020 Introduction: Graves’ disease (GD), an autoimmune disorder caused by high levels of auto-antibodies against the thyroid-stimulating hormone receptor, is considered the most common cause of thyrotoxicosis, characterized by features such as goiter ...
Tiucă Robert Aurelian +3 more
doaj +1 more source
Pulmonary Circulation, Volume 16, Issue 1, January 2026.ABSTRACT Long‐term intravenous (IV) epoprostenol is a key therapy for pulmonary arterial hypertension (PAH); however, rare immune‐mediated conditions occurring during therapy remain incompletely characterised. We report a 34‐year‐old man with idiopathic PAH who developed low‐grade fever and bilateral pulmonary infiltrates after 11 years of IV ...
Takashi Inao +9 more
wiley +1 more source
Journal of Ardabil University of Medical Sciences, 2015 Backgrounds & objectives: In addition to their genomic actions, thyroid hormones (THs) can modulate the immune responses through cell surface receptors. One of these is the antiviral effect of THs. Methimazole, as an anti-thyroid compound, is widely used
Hadi Feizi +3 more
doaj